A novel inhaled phosphodiesterase 4 inhibitor (CHF6001) reduces the allergen challenge response in asthmatic patients
Singh, D., Leaker, B., Boyce, M., Nandeuil, M.A., Collarini, S., Mariotti, F., Santoro, D., Barnes, P.J.Volume:
40
Language:
english
Journal:
Pulmonary Pharmacology & Therapeutics
DOI:
10.1016/j.pupt.2016.06.011
Date:
October, 2016
File:
PDF, 470 KB
english, 2016